NCT01857583View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Venous Thromboembolism
Interventions
DRUG

15mg DU-176b

DRUG

30mg DU-176b

DRUG

Fondaparinux

Trial Locations (1)

078-8237

Toyooka Chuo Hospital, Asahikawa

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY